Skip to main content
Clinical Trials/EUCTR2017-003626-32-AT
EUCTR2017-003626-32-AT
Active, not recruiting
Phase 1

Photodynamic therapy (pdt) for skin rejuvenation: A pilotstudy evaluating theeffectiveness of two modalities of photodynamic therapy in the treatment of photodamaged skin - ST-PDT vs. DL-PDT in treatment of photodamage

Medizinische Universität Wien, Univ. Klinik f. Dermatologie0 sites20 target enrollmentStarted: November 16, 2017Last updated:

Overview

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Medizinische Universität Wien, Univ. Klinik f. Dermatologie
Enrollment
20

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Patients between 50 and 85 with photodamaged skin and a photoaging score of 8 or more as well as skin type I\-III
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 5
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 15

Exclusion Criteria

  • Known allergy to aminlevulinic acid
  • Patients with porphyria or taking photosensitizing drugs
  • Patients with severe compromised general state
  • Patients with other dermatological diseases in the treatment area
  • Patient with another skin rejuvenation treatment in the last 6 moths
  • Patients unable to stick to the study protocol
  • Pregnant or lactating women
  • Patients who are participating in another study

Investigators

Sponsor
Medizinische Universität Wien, Univ. Klinik f. Dermatologie

Similar Trials